| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q3 2023 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Opendoor Technologies, Inc. | 4 | Q3 2021 | 100.0% |
| Impel NeuroPharma, Inc. | 2 | Q3 2021 | 62.1% |
View Norwest Venture Partners XIV, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Dave Inc./DE | February 14, 2023 | 18,645,614 | 5.7% |
| IMPEL NEUROPHARMA INC | August 10, 2021 | 3,077,198 | 13.8% |
View Norwest Venture Partners XIV, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-02-14 |
| SC 13G | 2023-02-14 |
| 13F-HR | 2021-10-27 |
| 13F-HR | 2021-08-10 |
| SC 13G | 2021-08-10 |
| 4 | 2021-04-29 |
| 4 | 2021-04-26 |
| 3 | 2021-04-22 |
| 13F-HR | 2021-04-21 |
| 13F-HR | 2021-02-16 |
View Norwest Venture Partners XIV, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.